FORUS Therapeutics
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 N Service Rd W Ste 129, Oakville, On...Website
www.forustherapeutics.comRevenue
<$5 MillionIndustry
About FORUS Therapeutics
FORUS Therapeutics Org Chart
Is FORUS Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on FORUS Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when FORUS Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at FORUS Therapeutics
Click to see if FORUS Therapeutics had a recent Job posting/layoffs
FORUS Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once FORUS Therapeutics has new funding data
Check if FORUS Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if FORUS Therapeutics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to FORUS Therapeutics
Compare insights from companies similar to FORUS Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FORUS Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
FORUS Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about FORUS Therapeutics.
FORUS Therapeutics Tech Stack
A closer look at the technologies used by FORUS Therapeutics
FORUS Therapeutics News & Media
FORUS Therapeutics Inc et l'Alliance pancanadienne pharmaceutique (APP) ont achevé les négociations concernant XPOVIO(MD) (sélinexor)
L'accord avec l'APP soutiendra le référencement public et le remboursement de XPOVIO.XPOVIO représente la première nouvelle classe de médicaments pour le traitement du myélome multiple récidivant ou réfractaire précoce introduit au Canada au cours des 7 dernières années.XPOVIO, un inhibiteur sélectif de la protéine d'exportation nucléaire (SINE) XPO1, offre aux experts traitant le myélome et aux patients un mécanisme d'action unique qui fonctionne efficacement avec d'autres traitements et permetFORUS Therapeutics Inc and the Pan-Canadian Pharmaceutical Alliance (pCPA) Complete Negotiations for XPOVIO(R)(selinexor)
The pCPA agreement will support the public listings and reimbursement of XPOVIO. XPOVIO represents the first new drug class for the treatment of early relapsed or refractory multiple myeloma introduced into Canada within the last 7 years. XPOVIO, a Selective Inhibitor of the Nuclear Export (SINE) protein XPO1, offers myeloma treaters and patients a unique mechanism of action that works effectively with other treatments and provides rapid and durable responses.Oakville, Ontario--(Newsfile...
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding FORUS Therapeutics
FORUS Therapeutics is a Canadian biopharmaceutical company focused on developing innovative medicines for hematologic malignancies and various types of cancer. The company aims to provide differentiated treatment options to improve patient outcomes. Their target clients include healthcare professionals and institutions involved in oncology and hema... Read More